Kineta, Inc/de 10-K annual reports
Annual reports — audited financials, the full risk-factor list, and management’s account of the year.
KANT
Kineta, Inc/deKineta, Inc. files an amendment to its 2024 Annual Report on Form 10-K to include previously omitted information regarding directors, executive officers, corporate governance, and executive compensation.
KANT
Kineta, Inc/deKineta, Inc. is exploring strategic alternatives, including a potential merger with TuHURA Biosciences, while facing financial challenges and doubts about its ability to continue as a going concern.
KANT
Kineta, Inc/deKineta, Inc. is exploring strategic alternatives, including a potential sale or liquidation, after a significant restructuring and workforce reduction due to funding issues.